Sudafed is a brand name and registered trademark for over the counter (OTC) decongestants manufactured by McNeil Laboratories (a division of Johnson & Johnson) for sale in Australia, New Zealand, Canada, Ireland, South Africa, the United Kingdom, and the United States. Before being acquired by Johnson & Johnson in 2006, Sudafed was owned by Pfizer.
Sudafed is used to treat symptoms of the common cold, sinusitis and nasal congestion.
The original formulation of Sudafed contains the active ingredient pseudoephedrine, but formulations without pseudoephedrine are also being sold under the Sudafed brand.
Read more about Sudafed: Summary of Active Ingredients, Switch To Phenylephrine, Regulation On Sale